Silodosin (4mg) + Dutasteride (0.5mg)
Rapilif-D 4/0.5 Capsule is used in the treatment of benign prostatic hyperplasia.
1 Strip of 10 Capsules
Image shown is a representation and may slightly vary from the actual product. Every effort is made to maintain accuracy of all information displayed.
Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Rapilif-D 4/0.5 Capsule is to be taken with food.
This will help to avoid the side effects.
Rapilif-D 4/0.5 Capsule is a combination of two medicines: Silodosin and Dutasteride, which relieves the symptoms of benign prostatic hyperplasia. Silodosin is an alpha-blocker. It works by relaxing the muscle around the bladder exit and prostate gland so as to allow easy passage of urine. Dutasteride is a 5-alpha-reductase inhibitor which helps in shrinking the prostate by decreasing the level of the hormone which helps the prostate gland grow.
Related Warnings
Taking Silodosin with alcohol may have additive effects in lowering your blood pressure. You may experience a headache, dizziness, lightheadedness, fainting, and/or changes in pulse or heart rate.
Rapilif-D 4/0.5 Capsule is highly unsafe to use during pregnancy.
Human and animal studies have shown significant adverse effects on the foetus. Please consult your doctor.
No information is available on the use of Rapilif-D 4/0.5 Capsule during lactation. Please consult your doctor.
Dizziness or weakness due to low blood pressure may occur in some patients while on Rapilif-D 4/0.5 Capsule. If you are affected in this way, your ability to drive may be impaired.
Rapilif-D 4/0.5 Capsule is probably safe to use in patients with kidney disease. Limited data available suggests that dose adjustment of Rapilif-D 4/0.5 Capsule may not be needed in these patients. Please consult your doctor.
Rapilif-D 4/0.5 Capsule should be used with caution in patients with liver disease. Dose adjustment of Rapilif-D 4/0.5 Capsule may be needed. Please consult your doctor.
Use of Rapilif-D 4/0.5 Capsule is not recommended in patients with severe liver disease.
